Canonical TGF-β Pathway Activity Is a Predictor of SHH-Driven Medulloblastoma Survival and Delineates Putative Precursors in Cerebellar Development-Reference-Cited by-同舟云学术

Canonical TGF-β Pathway Activity Is a Predictor of SHH-Driven Medulloblastoma Survival and Delineates Putative Precursors in Cerebellar Development

Published:2012-10-11 Issue:2 Volume:23 Page:178-191
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathology

Author:

Aref Donya,Moffatt Connor J.,Agnihotri Sameer¹,Ramaswamy Vijay¹,Dubuc Adrian M.¹,Northcott Paul A.¹,Taylor Michael D.¹,Perry Arie²,Olson James M.³,Eberhart Charles G.⁴,Croul Sidney E.

Affiliation:

1. Arthur and Sonia Labatt Brain Tumor Research Centre; Hospital for Sick Children, University of Toronto; Toronto; ON; Canada

2. Division of Neuropathology; University of California in San Francisco; San Francisco; CA

3. Department of Laboratory Medicine; Fred Hutchinson Cancer Research Center; University of Washington/Children's Hospital; Seattle; WA

4. Department of Pathology; Johns Hopkins University; Baltimore; MD

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

Reference55 articles.

1. Foxg1 dysregulation is a frequent event in medulloblastoma;Adesina;J Neurooncol,2007

2. Bone morphogenic protein 2 opposes SHH-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of nMyc;Alvarez-Rodriguez;J Biol Chem,2007

3. c-Myc expression and MEK1 induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer;Amatangelo;Carcinogenesis,2012

4. Medulloblastoma: update on a heterogeneous disease;Bourdeaut;Curr Opin Oncol,2011

5. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome;Cho;J Clin Oncol,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics;Current Pharmaceutical Design;2024-01

2. Building better brains: the pleiotropic function of neurotrophic factors in postnatal cerebellar development;Frontiers in Molecular Neuroscience;2023-05-12

3. Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors;Frontiers in Oncology;2023-03-24

4. Developmental Disorders of the Cerebellum and Neurotrophic Factors;Contemporary Clinical Neuroscience;2023

5. Clinical and Molecular Features in Medulloblastomas Subtypes in Children in a Cohort in Taiwan;Cancers;2022-11-03